Latest Breaking News On - Robertp charrow - Page 2 : comparemela.com
Greenberg Traurig Adds Former FDA Associate Chief Counsel for Litigation James Fraser in Firm s Washington D C Office
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Greenberg Traurig Continues Washington, D C Corporate Practice Expansion
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
To embed, copy and paste the code into your website or blog:
On 17 May 2021, the Acting Administrator of the Health Resources and Services Administration (HRSA), Diana Espinosa, sent letters to six pharmaceutical manufacturers stating that the manufacturers’ actions to limit access to 340B Program pricing for covered entities that dispense medications through contract pharmacies have resulted in overcharges and are in direct violation of the 340B statute.
1 The letters order the manufacturers to immediately begin offering 340B pricing to covered entities through their contract pharmacy arrangements or be subject to civil monetary penalties.
2 The letters represent the next key move by HRSA in the now nearly year-long battle over HRSA’s longstanding contract pharmacy guidance, which the manufacturers in question are challenging through refusing to replenish at 340B Program pricing. The letters led to a flurry of additional filings in the on-going litigation between the manufact
Advertisement
340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers that Their Contract Pharmacy Actions Violate 340B Statute Wednesday, May 26, 2021
On 17 May 2021, the Acting Administrator of the Health Resources and Services Administration (HRSA), Diana Espinosa, sent letters to six pharmaceutical manufacturers stating that the manufacturers’ actions to limit access to 340B Program pricing for covered entities that dispense medications through contract pharmacies have resulted in overcharges and are in direct violation of the 340B statute.
1 The letters order the manufacturers to immediately begin offering 340B pricing to covered entities through their contract pharmacy arrangements or be subject to civil monetary penalties.
Share
WASHINGTON, D.C. – May 25, 2021 – The former U.S. Department of Health and Human Services (HHS) General Counsel, Robert P. Charrow, has returned to the Washington, D.C. office of global law firm Greenberg Traurig, LLP. Charrow joins as senior chairman of the firm’s Health Care & FDA Practice.
“Bob is a proven leader and key figure in the health care industry. Indeed, he was previously a valued leader and part of the firm s cultural and quality fabric his first time with us. Having him rejoin at this time speaks to his and our commitment to Washington, D.C. and to the many stakeholders in an industry thrust into the limelight by the global health crisis - as well as our ability to serve the many private equity investors so active in the space,” said Richard A. Rosenbaum, Greenberg Traurig’s Executive Chairman. “Bob’s return to Greenberg Traurig is one aspect of our strategy to grow in elite areas of practice in which we are already recognized as best in class
vimarsana © 2020. All Rights Reserved.